The fiscal 2020 federal budget package signed into law on Dec. 20 increased funding for the FDA for the third time in three years.
The budget includes $3.16 billion in appropriations for the agency, an increase of three percent on the fiscal 2019 allocation. Including user fees, the agency’s total budget for fiscal 2020 is $5.8 billion.
Following two previous years of significant increases the agency is no longer “running on fumes” according to the Alliance for a Stronger FDA.
The budget expands funding for human drugs by $20 million to $683 million and for biologics by $12 million to $252 million. It includes additional funding for advanced manufacturing, opioids and rare cancer therapies.
The agency also received additional funding for the 21st Century Cures Act of $5 million for a total of $75 million.